InvestorsHub Logo

kei

12/19/14 7:25 AM

#84738 RE: kei #84737

OREX - Orexigen's Mysimba™ (naltrexone HCl / bupropion HCl prolonged release) Receives Positive CHMP Opinion Recommending Approval for Weight Management in the European Union

http://finance.yahoo.com/news/orexigens-mysimba-naltrexone-hcl-bupropion-121900320.html

now, imo, earning next year like 2nd q 3rdq 4thq will be very interesting since takeda will push their products in eu